Results 181 to 190 of about 374,223 (267)

Seroprevalence of Hepatitis E Virus Infection Among People Living With HIV in the Central African Republic

, 2018
Ornella Anne Demi Sibiro, Alexandre Manirakiza, Narcisse Komas   +2 more
openalex   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Acute hepatitis E virus infection as a trigger for postinfectious IgA nephropathy: A rare case report. [PDF]

Medicine (Baltimore)
Khan M, Khan Z, Altaf A, Bibi S, Batool I, Naamani AER, Fakih N.   +6 more
europepmc   +1 more source

Seroprevalence of hepatitis E among restaurant food handlers in Ibadan, Nigeria

, 2018
Adeola Fowotade, Akande Oluseyi, Adebimpe T. Gbaja, Victoria O. Ogunleye, Ayomide Ajayi, Aderemi Kehinde   +5 more
openalex   +2 more sources

Diagnostic Value of Immunoglobulin G (IgG) and IgM Anti-Hepatitis E Virus (HEV) Tests Based on HEV RNA in an Area Where Hepatitis E Is Not Endemic [PDF]

, 2000
Chen‐Chun Lin, Jaw‐Ching Wu, Ting‐Tsung Chang, Wen‐Yu Chang, Ming‐Lung Yu, Albert W. Tam, Shen-Chin Wang, Yi‐Hsiang Huang, Full‐Young Chang, Shou‐Dong Lee   +9 more
openalex   +1 more source

Psychoactive prescription drug use and misuse in patients on opioid agonist treatment

British Journal of Clinical Pharmacology, EarlyView.
Aims To identify the patterns and trends in prescription drug use and misuse in patients on opioid agonist treatment. Methods We used data from the OPPIDUM programme, which collects data from patients attending substance abuse treatment facilities. Data collected include use of psychoactive prescription drugs in the past week.
Thomas Soeiro, Clémence Lacroix, Élisabeth Jouve, Élisabeth Frauger, Maryse Lapeyre‐Mestre, Joëlle Micallef   +5 more
wiley   +1 more source

Prevalence of Hepatitis E genotype 3 among liver disease patients in Southwestern Nigeria. [PDF]

Virol J
Akanbi OA, Oluremi AS, Japhet MO, Osundare FA, Klink P, Harms D, Bock CT, Opaleye OO.   +7 more
europepmc   +1 more source

Screening for Hepatitis E virus (HEV) in slaughtered pig for meat in Uyo using both serological and molecular methods and assessing their public health appraisal

M.O. Irabor, Anthony A. Adegoke, C.U. Inyang, Opeyemi K. Fatunla, Moses E. Ekpenyong   +4 more
openalex   +2 more sources

Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment

British Journal of Clinical Pharmacology, EarlyView.
Aims Crisugabalin is a novel calcium channel α2δ subunit ligand and a highly selective oral gamma‐aminobutyric acid (GABA) analogue developed for the treatment of diabetic peripheral neuropathic pain (DPNP) and postherpetic neuralgia (PHN). This study investigated pharmacokinetic properties and safety of crisugabalin in subjects with renal impairment ...
Shibeilei Lin, Ye Wang, Chao Hu, Yanhuan Feng, Xi Tang, Ping Fu, Jia Miao   +6 more
wiley   +1 more source

Hepatitis E virus in immunocompromised children in Argentina: first report from a high-risk group. [PDF]

Virol J
Acosta J, Costaguta G, Gardiol D, Álvarez F, Costaguta A, Cavatorta AL.   +5 more
europepmc   +1 more source